Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Retatrutide needs additional TRIUMPH trial results throughout 2026 before submitting for FDA approval in late 2026 or early 2027, with approval expected in late 2027 and launch in early 2028
The researchers termed this "chronic cytoprotection." The cell-protection effect did not diminish with extended use
Anyone under 21 should avoid REGEN unless under medical supervision, as peptide effects on developing bodies are not well studied
Your provider sets the exact amount after evaluating your labs, so it is not a fixed number for everyone
Test Code(s): 007700 Biomarkers Tested (1): Total Glutathione Specimen: Blood Preparation: No special preparation required
